Biomarkers in a blink
Enhance neurologic care with eye movements biomarkers
Now CE-marked as a Class IIa medical device
Approved and available for clinical use across Europe
Our mission
Helping identify neurological diseases years before symptoms are visible and follow their progress objectively

Why eye movements
5 min
5 years
80 000
neuroClues®
An easy-to-use eye-tracking environment
to help practitioners instantaneously quantify their clinical exam
Based on years of research, it is designed to bring non-invasive, quick, and robust biomarkers.
neuroClues® has the ambition to provide:
- A better aid in diagnosis thanks to its sensitivity and specificity for ruling out differential diagnosis
- A better follow-up of the patients with its objective measurements of the evolution of the disease and the efficacy of the treatment
- An intuitive research tool with high spatial and temporal resolution
neuroClues® is a registered brand of P3Lab. In the European Union, neuroClues® is CE-marked as a Class IIa medical device. Note that neuroClues® may not be for sale in your country. Outside the European Union, neuroClues® will be available for sale as soon as regulatory approvals are obtained.



Testimonials
Our scientific advisory board testifies












About eye-tracking
Over the last 60 years, over 80 000 scientific articles have been written linking eye movement to neurological diseases
Eye-tracking enables measurements and analysis, allowing neurologists to increase their diagnosis certainty in few minutes and have a better follow-up of the patients.
Latest news

Reliability of Oculomotor Biomarkers
Discover the reliability of oculomotor biomarkers and how consistent eye movement metrics support early detection of neurological disorders

Exploring Anti-Saccades and Frontal Lobe Function
Learn more about how neuroClues® eye movement biomarkers could support early detection of cognitive impairments.

Neural Pathways of Voluntary and Reflexive Saccades
Learn more about the differences between voluntary and reflexive saccades, the structures involved in those movements, and how they can provide interesting clues about brain health.

Oculomotor Biomarkers Recorded on 50 Patients with neuroClues®, now CE-Marked!
Learn more about neuroClues®’ role in the ICEBERG cohort with 50 patients recorded, and how eye movement analysis is advancing cognitive impairment detection.